Tremelimumab With or Without Cryoablation in Treating Patients With Metastatic Kidney Cancer
Condition(s):Clear Cell Renal Cell Carcinoma; Metastatic Renal Cell Cancer; Stage IV Renal Cell Cancer AJCC v7Last Updated:July 7, 2022Completed
Hide Studies Not Open or Pending
Condition(s):Clear Cell Renal Cell Carcinoma; Metastatic Renal Cell Cancer; Stage IV Renal Cell Cancer AJCC v7Last Updated:July 7, 2022Completed
Condition(s):Clear Cell Renal Cell Carcinoma; Stage I Renal Cell Cancer AJCC v6 and v7; Stage II Renal Cell Cancer AJCC v7; Stage III Renal Cell Cancer AJCC v7Last Updated:February 8, 2022Completed
Condition(s):Clear Cell Renal Cell Carcinoma; Recurrent Renal Cell Cancer; Stage IV Renal Cell CancerLast Updated:August 4, 2021Completed
Condition(s):Renal Cell Carcinoma; Kidney Neoplasm; Renal Cancer; Kidney CancerLast Updated:October 10, 2022Completed
Condition(s):Cadonilimab; Clear Cell Renal Cell Carcinoma; Neoadjuvant TherapyLast Updated:November 18, 2023Recruiting
Condition(s):Clear Cell Renal Cell Carcinoma; Recurrent Renal Cell Cancer; Stage IV Renal Cell CancerLast Updated:June 8, 2017Terminated
Condition(s):Renal Cell CarcinomaLast Updated:August 24, 2023Terminated
Condition(s):Clear Cell Renal Cell Carcinoma; Metastatic Kidney Carcinoma; Stage IV Renal Cell Cancer AJCC v7Last Updated:December 8, 2023Active, not recruiting
Condition(s):Clear Cell Renal Cell Carcinoma; Recurrent Renal Cell Carcinoma; Stage IV Renal Cell CancerLast Updated:September 16, 2016Completed
Condition(s):Kidney CancerLast Updated:May 3, 2017Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.